PIM-3 kinase as a target for type 2 diabetes mellitus
Details for Australian Patent Application No. 2003202579 (hide)
International Classifications
Event Publications
10 April 2003 Complete Application Filed
Priority application(s): 02001401.5 19.01.02 EP
4 September 2003 Application Open to Public Inspection
Published as AU-B-2003202579
22 December 2005 Assignment before Grant
Aventis Pharma Deutschland GmbH The application has been assigned to Sanofi-Aventis Deutschland GmbH
3 May 2007 Application Accepted
Published as AU-B-2003202579
30 August 2007 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003202580-Amidoacetonitrile derivatives
2003202578-LIGHTING SYSTEM COMPRISING A NESTED COLLECTOR FOR ANNULARLY ILLUMINATING AN EXIT PUPIL
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser